Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MEI Pharma Inc.
DescriptionPI3K delta inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat B cell malignancies
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today